Sabra Health Care REIT reiterates 2026 guidance as senior housing NOI rises

Sabra Health Care REIT

03/08/2026 21:14

Overview
US healthcare REIT's Q2 revenue rose yr/yr, driven by higher resident fees and services
Adjusted FFO per share for Q2 was $0.39
Company closed $274.1 mln in senior housing and skilled nursing investments during Q2

Outlook
Sabra reiterates its full-year 2026 guidance issued in July 2026
Company expects to close about $100 mln in additional investments by year-end
Company says investment pipeline remains robust, focused on senior housing opportunities

Result Drivers
MANAGED SENIOR HOUSING GROWTH - Same property managed senior housing Cash NOI rose 13.7% yr/yr in Q2, reflecting improved segment performance
NEW INVESTMENTS - Co closed $274.1 mln in senior housing and skilled nursing investments in Q2 at an average initial cash yield of 8.1%
RENT RESET - Rent reset under Avamere lease increased annualized fixed cash rent to $48 mln, retroactive to Feb 1, 2026

Company press release: ID:nBw3GPcDMa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Rental Revenue
 
$101.31 mln
 
Q2 Net Loss
 
$25.25 mln
 
Q2 Adjusted FFO Per Share
 
$0.39
 
Q2 Dividend
 
$0.30
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy."
Wall Street's median 12-month price target for Sabra Health Care REIT Inc is $23.00, about 8.6% above its July 31 closing price of $21.17
The stock recently traded at 29 times the next 12-month earnings vs. a P/E of 29 three months ago

Reuters Recommended Reads
Aug 3 - Alexander's Q2 net income surges on property sale gain
Aug 3 - Easterly Government Properties Q2 Core FFO beats estimates; raises 2026 outlook
Aug 3 - Singapore's Lendlease Global Commercial REIT FY gross revenue rises

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)